Siddharth Singh MD
Advanced Endoscopic Interventional, Inflammatory Bowel Disease
Physician
Join to View Full Profile
9500 Gilman Dr# MailLa Jolla, CA 92093
Phone+1 619-543-2347
Fax+1 858-657-7259
Dr. Singh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 2011 - 2014
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2008 - 2011
All India Institute of Medical SciencesClass of 2007
Certifications & Licensure
CA State Medical License 2015 - 2027
MN State Medical License 2011 - 2016
IA State Medical License 2008 - 2011
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients Start of enrollment: 2020 Dec 18
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- The Impact of Setons on Perianal Fistula Outcomes in Patients With Crohn's Disease Treated With Anti-TNF Therapy: A Multicentre Study.Jeffrey McCurdy, Javeria Munir, Simon Parlow, Gagan Sambhi, Jacqueline Reid
Alimentary Pharmacology & Therapeutics. 2025-05-01 - Reply.Siddharth Singh, M Hassan Murad, Ashwin N Ananthakrishnan
Gastroenterology. 2025-05-01 - LONG-TERM SUSTAINED IMPROVEMENT IN UNPLANNED HEALTHCARE UTILIZATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.Gil Y Melmed, Brant Oliver, Alice Kennedy, Jason K Hou, Donald Lum
The American Journal of Gastroenterology. 2025-04-07
Journal Articles
- Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Diarrhea in Patients with Inflammatory Bowel DiseasesWaseem Ahmad, Daniel Bouland, Nghia H Nguyen, David T Pride, Siddharth Singh, Parambir S Dulai, William J Sandborn, Brigid S Boland, Digestive Diseases and Sciences
- No Benefit of Concomitant 5-Aminosalicylates in Patients with Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data from Cli...Siddharth Singh, Parambir S Dulai, William J Sandborn, Nature
- Obesity and Response to Infliximab in Patients with Inflammatory Bowel Diseases: Pooled Analysis of Individual Participant Data from Clinical TrialsSiddharth Singh, William J Sandborn, Nature
Press Mentions
New CGH Special Issue: The Future of IBD CareFebruary 20th, 2025- List of Advanced Rx Recommended For Moderate to Severe UC ExpandsFebruary 4th, 2025
- New AGA Living Guideline Expands Recommended Drugs for Moderate to Severe UCNovember 26th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
